Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Essential meiotic structure-specific endonuclease 1 (EME1) is a structure-specific endonuclease that forms a functional complex with MUS81, participating in the cleavage and resolution of branched DNA structures such as nicked Holliday junctions, 3'-flaps, and stalled replication forks. This endonuclease complex plays a critical role in DNA damage repair—especially processing intermediates of homologous recombination and resolving DNA structures at stalled or collapsed replication forks—and is essential for maintaining genomic integrity. Its activity is tightly regulated by phosphorylation and protein-protein interactions, and it is particularly vital when other repair pathways (e.g., those involving the BLM helicase) are compromised[1][2][3][4][5].
DNA-damaging agents induce replication stress that requires EME1-mediated processing for cell survival; EME1 is part of a critical DNA repair endonuclease complex (often with MUS81) that cuts branched DNA structures to facilitate DNA repair[2][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Essential meiotic structure-specific endonuclease 1 (EME1).